Delivery Order SPE2D021DA002-SPE2D326F6876
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,210.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Procainamide 1 gram/10 mL vials. The contract, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency issued a $9,659.15 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract program with a $499.9 million ceiling authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $26,532.96 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. PPV-G GEN V is a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $14,837.67 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare...
- The Defense Logistics Agency issued a $2,041.58 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. The contract authorizes firm fixed-price delivery orders for branded and...
- The Defense Logistics Agency issued a $12,066.35 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling authorizing firm fixed-price delivery orders for branded and...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $10,844.40 delivery order to DMS Pharmaceutical Group Inc. on February 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical supply needs of military healthcare facilities...
- The Defense Logistics Agency issued a $1,557.44 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The parent IDC, awarded to the awardee on November 13, 2025, carries a $499.99 billion ceiling and extends through December 31, 2036, with a...
- The Defense Logistics Agency issued a $1,179.38 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. The PPV-G GEN V is a Defense Logistics Agency-administered indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...